Connexion
M'inscrire

Votre recherche

Filtres

Project précédent
Projet suivant
Nous verifions auprès de chaque centre si des nouvelles informations sont disponibles

IDE G210126

Pediatric influence of cooling duration on efficacy in cardiac arrest patients (p-icecap)
Source : Importé depuis le centre

Référence clinicaltrials.gov: NCT05376267
Bayesian Adaptive Clinical Trial
Hypothermia
therapeutic
Coma
Pediatric
Source : Importé depuis le centre
Recrutement partiellement ouvert
Dernière modification : 2025/04/24
Type de recherche

Interventionnel


Population cible

Condition médicale (spécialité visée)

Donnée non disponible

Profil des participants

Sexe(s) des participants

ALL

Source : Importé depuis le centre

Critères de sélection

Critères d'inclusion

Inclusion criteria:

* Age 2 days to \< 18 years with corrected gestational age of at least 38 weeks
* Chest compressions for at least 2 minutes
* Coma or encephalopathy after resuscitation from Out-of-Hospital Cardiac Arrest (OHCA)
* Requires continuous mechanical ventilation through endotracheal tube or tracheostomy
* Definitive temperature control device initiated
* Randomization within 6 hours of Return of Spontaneous Circulation (ROSC)
* Informed consent from Legally Authorized Representative (LAR) including intent to maintain life support for 120 hours

Exclusion criteria:

* Glasgow Coma Motor Score (GCMS) = 6
* LAR does not speak English or Spanish
* Duration of Cardiopulmonary Resuscitation (CPR) \> 60 minutes
* Severe hemodynamic instability with continuous infusion of epinephrine or norepinephrine of 2 micrograms per kilogram per minute (μg/kg/minute) or initiation of Extracorporeal membrane oxygenation (ECMO)
* Pre-existing severe neurodevelopmental deficits with Pediatric Cerebral Performance Category (PCPC) =5 or progressive degenerative encephalopathy
* Pre-existing terminal illness, unlikely to survive to one year
* Cardiac arrest associated with brain, thoracic, or abdominal trauma
* Active and refractory severe bleeding prior to randomization
* Extensive burns or skin lesions incompatible with surface cooling
* Planned early withdrawal of life support before 120 hours
* Sickle cell anemia
* Pre-existing cryoglobulinemia
* Non-fatal drowning in ice covered water
* Central nervous system tumor with ongoing chemotherapy
* Previous enrollment in P-ICECAP trial
* Prisoner
* Chronic hypothermia
* New post-cardiac arrest diabetes insipidus
* Pregnancy

Source : Importé depuis le centre

Thérapie ou Intervention proposée

Cohortes
Nom Condition médicale Traitement État du recrutement
Cooling 0 hours Participants will be kept at a normal temperature for the whole 5 days. Donnée non disponible
  • Inconnu
  • Cooling 12 hours The participant will be cooled to 33°Celsius (C) for 12 hours, slowly rewarmed over approximately 16 hours, and then will be kept at a normal temperature (36.8°C or 98.6°F) until the end of the 5th day. Donnée non disponible
  • Inconnu
  • Cooling 18 hours The participant will be cooled to 33°C for 18 hours, slowly rewarmed over approximately 16 hours, and then will be kept at a normal temperature (36.8°C or 98.6°F) until the end of the 5th day. Donnée non disponible
  • Inconnu
  • Cooling 24 hours The participant will be cooled to 33°C for 24 hours, slowly rewarmed over approximately 16 hours, and then will be kept at a normal temperature (36.8°C or 98.6°F) until the end of the 5th day. Donnée non disponible
  • Inconnu
  • Cooling 36 hours The participant will be cooled to 33°C for 36 hours, slowly rewarmed over approximately 16 hours, and then will be kept at a normal temperature (36.8°C or 98.6°F) until the end of the 5th day. Donnée non disponible
  • Inconnu
  • Cooling 48 hours The participant will be cooled to 33°C for 48 hours, slowly rewarmed over approximately 16 hours, and then will be kept at a normal temperature (36.8°C or 98.6°F) until the end of the 5th day. Donnée non disponible
  • Inconnu
  • Cooling 60 hours The participant will be cooled to 33°C for 60 hours, slowly rewarmed over approximately 16 hours, and then will be kept at a normal temperature (36.8°C or 98.6°F) until the end of the 5th day. Donnée non disponible
  • Inconnu
  • Cooling 72 hours The participant will be cooled to 33°C for 72 hours, slowly rewarmed over approximately 16 hours, and then will be kept at a normal temperature (36.8°C or 98.6°F) until the end of the 5th day. Donnée non disponible
  • Inconnu
  • Cooling 84 hours The participant will be cooled to 33°C for 84 hours, slowly rewarmed over approximately 16 hours, and then will be kept at a normal temperature (36.8°C or 98.6°F) until the end of the 5th day. Donnée non disponible
  • Inconnu
  • Cooling 96 hours The participant will be cooled to 33°C for 96 hours, slowly rewarmed over approximately 16 hours, and then will be kept at a normal temperature (36.8°C or 98.6°F) until the end of the 5th day. Donnée non disponible
  • Inconnu
  • Cooling 0 hours
    État du recrutement
    unknown
    Cooling 12 hours
    État du recrutement
    unknown
    Cooling 18 hours
    État du recrutement
    unknown
    Cooling 24 hours
    État du recrutement
    unknown
    Cooling 36 hours
    État du recrutement
    unknown
    Cooling 48 hours
    État du recrutement
    unknown
    Cooling 60 hours
    État du recrutement
    unknown
    Cooling 72 hours
    État du recrutement
    unknown
    Cooling 84 hours
    État du recrutement
    unknown
    Cooling 96 hours
    État du recrutement
    unknown
    Données à jour depuis : 24 avril 2025

    Description de l'étude

    Résumé de l'étude

    This is a multicenter trial to establish the efficacy of cooling and the optimal duration of induced hypothermia for neuroprotection in pediatric comatose survivors of cardiac arrest.

    The study team hypothesizes that longer durations of cooling may improve either the proportion of children that attain a good neurobehavioral recovery or may result in better recovery among the proportion already categorized as having a good outcome.

    Source : Importé depuis le centre

    Sites

    Centres participants


    Dernière modification : 24 avril 2025
    Données à jour depuis : 26 avr.
    Origine des données : clinicaltrials.gov
    Référence clinicaltrials.gov: NCT05376267